TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 117 filers reported holding TCR2 THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 3.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $492,000 | – | 30,000 | – | 7.76% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 4,050,865 | $62,221,000 | 18.51% |
MPM BioImpact LLC | 3,370,982 | $51,778,000 | 13.77% |
Redmile Group, LLC | 1,765,188 | $27,113,000 | 0.50% |
ArrowMark Colorado Holdings LLC | 1,356,010 | $20,828,000 | 0.22% |
DAFNA Capital Management LLC | 46,183 | $709,000 | 0.20% |
Artal Group S.A. | 350,000 | $5,376,000 | 0.15% |
WFA of San Diego, LLC | 4,733 | $540,000 | 0.13% |
Granite Point Capital Management, L.P. | 100,000 | $1,536,000 | 0.08% |
HHLR ADVISORS, LTD. | 322,903 | $4,960,000 | 0.04% |
SPHERA FUNDS MANAGEMENT LTD. | 30,000 | $461,000 | 0.04% |